Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244504 | SCV000307214 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000244504 | SCV000729996 | likely benign | not specified | 2017-10-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000641422 | SCV000763063 | uncertain significance | Nemaline myopathy 2 | 2017-12-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000641422 | SCV001456740 | likely benign | Nemaline myopathy 2 | 2020-05-30 | no assertion criteria provided | clinical testing |